Last reviewed · How we verify
NCT06114160: Coqueluche-Vac
Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy
trial testing Data collection in Pertussis in 500 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | Université de Reims Champagne-Ardenne |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 December 2023 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 May 2024 |
Drugs / interventions tested
- Data collection — full drug profile →
Conditions studied
- Pertussis — all drugs for Pertussis →
Sponsor
Université de Reims Champagne-Ardenne
Who can join
18 and older, female only, with Pertussis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In France, it has been recommended since 2022 that pregnant women be vaccinated against pertussis from 20 to 36 weeks' gestation. This vaccination schedule is inspired by the Anglo-Saxon model and studies showing the effectiveness of this practice. The aim of this vaccine is to protect the newborn by transferring antibodies from the fetus to the placenta, because Pertussis is a particularly serious disease in newborns.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06114160
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Data collection
Trials testing the same drug.
- NCT07010562 — A Multi-site, Pre-clinical, Prospective Data Collection Study in Patients Undergoing a Right Heart Catheterization · not yet recruiting
- NCT07418359 — Comparison of Patient's Physical Activity Levels According to the Physical Activity Level of Their General Practitioner · recruiting
- NCT07197398 — Preoperative Data and the Spinal Spread of Local Anesthetic in Cesarean Section · recruiting
- NCT06998797 — Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study · not yet recruiting
- NCT07529730 — Outcomes of Surgical Treatment in Patients With Infective Endocarditis · completed
Other recruiting trials for Pertussis
Currently open trials in the same condition.
- NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
- NCT06708286 — A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) · Phase 2, PHASE3 · active not recruiting
- NCT06184542 — Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine · Phase 1 · recruiting
- NCT06286007 — Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control · recruiting
- NCT06056050 — A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) · Phase 1 · active not recruiting
Other Université de Reims Champagne-Ardenne trials
Trials by the same sponsor.
- NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
- NCT07418359 — Comparison of Patient's Physical Activity Levels According to the Physical Activity Level of Their General Practitioner · recruiting
- NCT07424937 — Prevalence of Regular Gynecological Follow-up Among Women of Childbearing Age · completed
- NCT07440082 — Resumption of Sexual Intercourse in the Postpartum Period: Women's Experiences · completed
- NCT07241299 — Understanding Chronic Treatments by Patients Over 65 Years of Age · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06114160 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Université de Reims Champagne-Ardenne
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06114160.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing